According to Mirum Pharmaceuticals's latest financial reports the company has $0.28 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.15 B | -3.08% |
2021-12-31 | $0.15 B | -32.47% |
2020-12-31 | $0.23 B | 98.71% |
2019-12-31 | $0.11 B | 124.51% |
2018-12-31 | $51.96 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | -27.29% | ๐บ๐ธ USA |